blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP0833894

EP0833894 - RAPAMCYCIN-BASED REGULATION OF BIOLOGICAL EVENTS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  19.06.2009
Database last updated on 25.09.2024
Most recent event   Tooltip20.05.2011Lapse of the patent in a contracting state
New state(s): GR		published on 22.06.2011  [2011/25]
Applicant(s)For all designated states
ARIAD GENE THERAPEUTICS, INC.
26 Landsdowne Street
Cambridge, MA 02139-4234 / US
[2008/28]
Former [1998/15]For all designated states
ARIAD GENE THERAPEUTICS, INC.
26 Landsdowne Street
Cambridge, MA 02139 / US
Inventor(s)01 / CLACKSON, Timothy
25 Ivaloo Street
Somerville, MA 02143 / US
02 / HOLT, Dennis, A.
7 Brookmill Road
Stow, MA 01775 / US
03 / GILMAN, Michael, Z.
555 Chestnut Street
Newton, MA 02168 / US
[1998/15]
Representative(s)Jaenichen, Hans-Rainer
Vossius & Partner
Postfach 86 07 67
81634 München / DE
[N/P]
Former [1998/15]Jaenichen, Hans-Rainer, Dr.
Vossius & Partner, Postfach 86 07 67
81634 München / DE
Application number, filing date96921491.507.06.1996
[1998/15]
WO1996US09948
Priority number, dateUS1995048194107.06.1995         Original published format: US 481941
US19960015502P09.02.1996         Original published format: US 15502 P
[1999/18]
Former [1998/29]US1995048194107.06.1995
US1996001550209.02.1996
Former [1998/15]US1995048194107.06.1995
US1996059877609.02.1996
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9641865
Date:27.12.1996
Language:EN
[1996/56]
Type: A1 Application with search report 
No.:EP0833894
Date:08.04.1998
Language:EN
The application published by WIPO in one of the EPO official languages on 27.12.1996 takes the place of the publication of the European patent application.
[1998/15]
Type: B1 Patent specification 
No.:EP0833894
Date:13.08.2008
Language:EN
[2008/33]
Search report(s)International search report - published on:EP27.12.1996
ClassificationIPC:C12N5/10, C12N9/90, C12N15/12, C12N15/10, C12N15/31, C12N15/62, C12N15/63, C12N15/85, C12N15/86, C07K14/395, C07K14/47
[1998/15]
CPC data not yet available
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1998/15]
TitleGerman:AUF RAPAMYCIN BASIERENDE REGULATION BIOLOGISCHER VORGÄNGE[1998/15]
English:RAPAMCYCIN-BASED REGULATION OF BIOLOGICAL EVENTS[1998/15]
French:REGULATION D'EVENEMENTS BIOLOGIQUES FONDEE SUR LA RAPAMYCINE[1998/15]
Entry into regional phase07.01.1998National basic fee paid 
07.01.1998Designation fee(s) paid 
07.01.1998Examination fee paid 
Examination procedure16.12.1996Request for preliminary examination filed
International Preliminary Examining Authority: EP
07.01.1998Examination requested  [1998/15]
05.06.2003Despatch of a communication from the examining division (Time limit: M06)
15.12.2003Reply to a communication from the examining division
08.07.2004Despatch of a communication from the examining division (Time limit: M04)
16.11.2004Reply to a communication from the examining division
21.06.2005Despatch of a communication from the examining division (Time limit: M06)
27.12.2005Reply to a communication from the examining division
11.12.2006Despatch of a communication from the examining division (Time limit: M04)
23.04.2007Reply to a communication from the examining division
02.08.2007Despatch of a communication from the examining division (Time limit: M03)
08.11.2007Reply to a communication from the examining division
08.01.2008Communication of intention to grant the patent
19.05.2008Fee for grant paid
19.05.2008Fee for publishing/printing paid
Opposition(s)14.05.2009No opposition filed within time limit [2009/30]
Fees paidRenewal fee
29.06.1998Renewal fee patent year 03
29.06.1999Renewal fee patent year 04
28.06.2000Renewal fee patent year 05
29.06.2001Renewal fee patent year 06
01.07.2002Renewal fee patent year 07
30.06.2003Renewal fee patent year 08
30.06.2004Renewal fee patent year 09
30.06.2005Renewal fee patent year 10
29.06.2006Renewal fee patent year 11
29.06.2007Renewal fee patent year 12
30.06.2008Renewal fee patent year 13
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT13.08.2008
BE13.08.2008
DK13.08.2008
FI13.08.2008
SE13.11.2008
GR14.11.2008
ES24.11.2008
PT13.01.2009
[2011/25]
Former [2010/19]AT13.08.2008
BE13.08.2008
DK13.08.2008
FI13.08.2008
SE13.11.2008
ES24.11.2008
PT13.01.2009
Former [2009/30]AT13.08.2008
BE13.08.2008
DK13.08.2008
FI13.08.2008
ES24.11.2008
PT13.01.2009
Former [2009/19]AT13.08.2008
BE13.08.2008
DK13.08.2008
FI13.08.2008
ES24.11.2008
Former [2009/14]AT13.08.2008
FI13.08.2008
ES24.11.2008
Former [2009/09]ES24.11.2008
Cited inInternational search[DA]WO9418317  (UNIV LELAND STANFORD JUNIOR [US], et al) [DA] 1-45 * the whole document *;
 [DA]WO9502684  (UNIV LELAND STANFORD JUNIOR [US], et al) [DA] 1-45 * the whole document *;
 [DPX]WO9533052  (MITOTIX INC [US]) [DPX] 36,37,39,45 * page 46, line 11 - page 47, line 28 * * page 47, line 29 - page 54, line 10 * * page 62, line 5 - page 63, line 30 *;
 [T]WO9606111  (ARIAD GENE THERAPEUTICS INC [US], et al) [T] 1-45 * cited in the application; page 94, line 1 - page 100, line 7 *;
 [DA]  - J.L. POMERANTZ ET AL., "Structure-based design of transcription factors", SCIENCE, AAAS,WASHINGTON,DC,US, (19950106), vol. 267, pages 93 - 96, XP002018160 [DA] 1-45 * the whole document *

DOI:   http://dx.doi.org/10.1126/science.7809612
 [DA]  - J. CHEN ET AL., "Identification of an 11-kDa FKBP 12-rapamycin-binding domain within the 289-kDa FKBP-rapamycin-associated protein and characterization of a critical serine residue", PROC. NATL.ACAD SCI., NATL. ACAD SCI.,WASHINGTON,DC,US;, (199505), vol. 92, pages 4947 - 4051, XP002018161 [DA] 1-45 * the whole document *

DOI:   http://dx.doi.org/10.1073/pnas.92.11.4947
 [T]  - RIVERA, VICTOR M. ET AL, "A humanized system for pharmacologic control of gene expression", NAT. MED. (N. Y.) (1996), 2(9), 1028-1032 CODEN: NAMEFI;ISSN: 1078-8956, (199609), XP002018162 [T] 1-45 * the whole document *

DOI:   http://dx.doi.org/10.1038/nm0996-1028
Examination   - CHIU ET AL, "RAPT1, a mammalian homolog of yeast Tor, interacts with the FKBP12 / rapamycin complex.", PNAS, (1994), vol. 91, pages 12574 - 12578
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.